[Comments on the indication of immunosuppressive long-term therapy in myasthenia gravis (author's transl)].
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced; D009157:Myasthenia Gravis / Q000188:drug therapy*
D002800:Cholinesterase Inhibitors; D001379:Azathioprine
Zur Frage der indikation einer immunsuppressiven Dauertherapie bei der Myasthenia gravis.